Discontinued Operations

12 Months Ended

Dec. 31, 2022

Discontinued Operations and Disposal Groups [Abstract]

On January 11, 2021, Evolent Health LLC, EH Holdings and True Health, each wholly owned subsidiaries of the Company, entered into a Stock Purchase Agreement (the “True Health SPA”) with Bright Health Management, Inc. (“Bright HealthCare”), pursuant to which EH Holdings agreed to sell all of its equity interests in True Health to Bright HealthCare. Closing of the transactions contemplated by the True Health SPA occurred on March 31, 2021 (the “True Health Closing”) and the Company has had no continuing involvement with True Health subsequent to the closing except a pre-existing services agreement for claims processing and other health plan administrative functions.

As of the first quarter of 2021, the Company determined that True Health met the discontinued operations criteria under ASC 205, and as such, True Health assets and liabilities and the results of operations for all periods presented are classified as discontinued operations and are not included in continuing operations in the consolidated financial statements.

The following table summarizes the results of operations of the Company’s True Health business, which are included in income from discontinued operations in the consolidated statements of operations and comprehensive income (loss):


	For the Year Ended December 31,
	2021		2020
Revenue
Platform and operations	$	38	$	356
Premiums	44,795		117,377
Total revenue	44,833		117,733

Expenses
Cost of revenue (exclusive of depreciation and amortization expenses presented separately below) (1)	5,885		18,343
Claims expenses	33,954		87,951
Selling, general and administrative expenses (2)	5,764		18,576
Depreciation and amortization expenses	160		640
Total operating expenses	45,763		125,510
Operating loss	(930)		(7,777)
Interest income	112		531
Interest expense	(4)		(12)
Other loss	(25)		(1)
Loss before income taxes and non-controlling interests	(847)		(7,259)
Provision for income taxes	(326)		(1,185)
Net loss	$	(521)	$	(6,074)

————————

(1)Cost of revenue includes intercompany expenses between the Company and True Health that are recorded in income from continuing operations in the consolidated statements of operations and comprehensive income (loss) related to an existing services agreement for claims processing and other health plan administrative functions of $2.8 million and $13.6 million for the years ended December 31, 2021 and 2020, respectively.

(2)Selling, general and administrative expenses include intercompany expenses between the Company and True Health that are recorded in income from continuing operations on the consolidated statements of operations and comprehensive income (loss) related to an existing services agreement for claims processing and other health plan administrative functions of $1.1 million and $6.4 million for the years ended December 31, 2021 and 2020, respectively.

The consolidated statements of cash flows for all periods have not been adjusted to separately disclose cash flows related to discontinued operations. Cash flows related to the True Health business were as follows:


	For the Year Ended December 31,
	2021		2020
Cash flows provided by operating activities	$	5,002	$	6,852
Cash flows (used in) provided by investing activities	(2,494)		2,636